CUAMC
VERV
China Universal Asset Management Company’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
17,904
+93
| +0.5% | +$1.04K | 0.02% | 312 |
|
|
2025
Q1 | $81.4K | Sell |
17,811
-141
| -0.8% | -$644 | 0.01% | 374 |
|
|
2024
Q4 | $101K | Buy |
17,952
+1,676
| +10% | +$9.45K | 0.01% | 388 |
|
|
2024
Q3 | $78.8K | Buy |
16,276
+6,412
| +65% | +$31K | 0.01% | 371 |
|
|
2024
Q2 | $48.1K | Sell |
9,864
-6,207
| -39% | -$30.3K | 0.01% | 360 |
|
|
2024
Q1 | $213K | Buy |
16,071
+7,256
| +82% | +$96.4K | 0.03% | 281 |
|
|
2023
Q4 | $123K | Buy |
8,815
+7,174
| +437% | +$100K | 0.02% | 257 |
|
|
2023
Q3 | $21.8K | Buy |
1,641
+829
| +102% | +$11K | 0.01% | 291 |
|
|
2023
Q2 | $15.2K | Sell |
812
-23
| -3% | -$431 | ﹤0.01% | 290 |
|
|
2023
Q1 | $12K | Buy |
835
+209
| +33% | +$3.01K | ﹤0.01% | 268 |
|
|
2022
Q4 | $12.1K | Buy |
626
+65
| +12% | +$1.26K | ﹤0.01% | 211 |
|
|
2022
Q3 | $19K | Buy |
+561
| New | +$19K | 0.01% | 161 |
|